Immunoassay News and Research

RSS
Reliable Antibodies Testing for SARS-CoV-2

Reliable Antibodies Testing for SARS-CoV-2

Rapid lateral flow immunoassay enables fluorescence detection of SARS-Cov-2 RNA

Rapid lateral flow immunoassay enables fluorescence detection of SARS-Cov-2 RNA

Researchers develop new serological assay for detection of SARS-CoV-2 antibodies

Researchers develop new serological assay for detection of SARS-CoV-2 antibodies

High-performing multi-immunoassay for early diagnosis and prognosis of COVID-19

High-performing multi-immunoassay for early diagnosis and prognosis of COVID-19

Antibody responses to SARS-CoV-2 virus disappear quickly during convalescence, indicates study

Antibody responses to SARS-CoV-2 virus disappear quickly during convalescence, indicates study

RUDN team suggests new tool to control inflammation in asthma patients with accompanying diseases

RUDN team suggests new tool to control inflammation in asthma patients with accompanying diseases

Siemens Healthineers SARS-CoV-2 IgG antibody test demonstrates ability to detect neutralizing antibodies

Siemens Healthineers SARS-CoV-2 IgG antibody test demonstrates ability to detect neutralizing antibodies

New analytical method to detect the patulin toxin in foods by using antibodies

New analytical method to detect the patulin toxin in foods by using antibodies

Basic concepts lay the foundation for personalized immunotherapy

Basic concepts lay the foundation for personalized immunotherapy

Care pathways for pregnant women with COVID‐19

Care pathways for pregnant women with COVID‐19

SARS-CoV-2-induces temporary loss of smell in mice

SARS-CoV-2-induces temporary loss of smell in mice

Beckman Coulter introduces new SARS-CoV-2 IgM assay in countries accepting the CE Mark

Beckman Coulter introduces new SARS-CoV-2 IgM assay in countries accepting the CE Mark

Critically ill COVID-19 patients experience novel platelet-activating immune complexes, study finds

Critically ill COVID-19 patients experience novel platelet-activating immune complexes, study finds

Study of SARS-CoV-2 antibodies in >5,000 healthcare workers

Study of SARS-CoV-2 antibodies in >5,000 healthcare workers

Reducing the airborne transmission risk for SARS-CoV-2

Reducing the airborne transmission risk for SARS-CoV-2

REACT study shows 26% decline in SARS CoV-2 seroprevalence over 2-3 months

REACT study shows 26% decline in SARS CoV-2 seroprevalence over 2-3 months

Mayo clinic researchers develop a potential test for Machado-Joseph disease

Mayo clinic researchers develop a potential test for Machado-Joseph disease

Porvair Sciences offers optimized microplates for affinity binding assays

Porvair Sciences offers optimized microplates for affinity binding assays

Rapid SARS‐CoV‐2 IgM‐IgG combined antibody test

Rapid SARS‐CoV‐2 IgM‐IgG combined antibody test

Temporal predictors of SARS-CoV-2 antibodies

Temporal predictors of SARS-CoV-2 antibodies